BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TVAX-008 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of TVAX-008\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07282249-9842@assetmemo.bio
DTSTAMP:20261121T005710Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:TVAX-008: Phase 3 readout est. (NCT07282249)
DESCRIPTION:TVAX-008\, phase 3\, Chronic Hepatitis B.\nStudy: Clinical Tria
 l to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatme
 nt of Chronic Hepatitis B\nEstimated primary completion: 30 April 2027. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/tvax-008#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT07282249
URL:https://assetmemo.bio/drug/tvax-008#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07876856-9842@assetmemo.bio
DTSTAMP:20261121T005710Z
DTSTART;VALUE=DATE:20280922
DTEND;VALUE=DATE:20280923
SUMMARY:TVAX-008: Phase 1/2 readout est. (NCT07876856)
DESCRIPTION:TVAX-008\, phase 1/2\, Chronic Hepatitis B.\nStudy: A Study of 
 Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection i
 n Participants Living With Chronic Hepatitis B (CHB)\nEstimated primary co
 mpletion: 22 September 2028. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/tvax-008#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07876856
URL:https://assetmemo.bio/drug/tvax-008#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07897448-9842@assetmemo.bio
DTSTAMP:20261121T005710Z
DTSTART;VALUE=DATE:20280922
DTEND;VALUE=DATE:20280923
SUMMARY:TVAX-008: Phase 1/2 readout est. (NCT07897448)
DESCRIPTION:TVAX-008\, phase 1/2\, Chronic Hepatitis B.\nStudy: A Study of 
 Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection i
 n Participants Living With Chronic Hepatitis B (CHB)\nEstimated primary co
 mpletion: 22 September 2028. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/tvax-008#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07897448
URL:https://assetmemo.bio/drug/tvax-008#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
